Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Shakeup at Intrexon as a Subsidiary is Created and an Ex-Pfizer Exec Exits in Reorg March 12, 2017 Zomedica Announces First Quarter 2017 Financial Results May 11, 2017 Auris Med Announces Receipt Of Nasdaq Notice August 24, 2017
